Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Dogar, Omara Fatima orcid.org/0000-0002-7122-8403, Keding, Ada orcid.org/0000-0002-1182-887X, Gabe, Rhian orcid.org/0000-0002-0273-3094 et al. (16 more authors) (2020) Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. The Lancet Global Health. e1408-e1417. ISSN 2214-109X

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.
Dates:
  • Accepted: 24 June 2020
  • Published: 1 November 2020
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Health Sciences (York)
The University of York > Faculty of Sciences (York) > Hull York Medical School (York)
The University of York > Faculty of Sciences (York) > Biology (York)
Depositing User: Pure (York)
Date Deposited: 01 Jul 2020 08:30
Last Modified: 23 May 2021 10:55
Published Version: https://doi.org/10.1016/S2214-109X(20)30312-0
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1016/S2214-109X(20)30312-0

Downloads

Filename: TB_Tobacco_main_trial_paper_v3.1_Clean.docx

Description: TB Tobacco main trial paper v3.1-Clean

Filename: Manuscript_tables_Rev2.docx

Description: Manuscript tables -Rev2

Filename: TB_Tobacco_Supplementary_Files_v3.1.docx

Description: TB & Tobacco Supplementary Files v3.1

Filename: PIIS2214109X20303120.pdf

Description: PIIS2214109X20303120

Licence: CC-BY 2.5

Share / Export

Statistics